Majority of AI clinical trials report positive outcomes, yet concerns over generalizability persist Post author: Post published:April 29, 2024 Post category:uncategorized The state of randomized controlled trials (RCTs) for artificial intelligence (AI) algorithms in clinical practice. You Might Also Like Lecanemab and donanemab slow Alzheimer’s decline, but is the benefit worth the cost? February 17, 2025 Study shows wearable health sensors only prompt a fraction of at-home tests July 24, 2024 Scientists discover key to activating natural killer cells against cancer August 28, 2024
Lecanemab and donanemab slow Alzheimer’s decline, but is the benefit worth the cost? February 17, 2025